Скачать или смотреть Brent Saunders, CEO & Chairman of Bausch + Lomb, In Conversation With Miami Herbert Business School

This event was recorded on September 18, 2024 at Miami Herbert Business School.

Brent Saunders is a proven leader with more than 25 years of experience across the health care sector. He has served in senior executive roles at several global pharmaceutical and healthcare companies, where he has successfully overseen numerous value-enhancing initiatives, transactions and integrations.

He rejoined Bausch + Lomb as Chief Executive Officer and Chairman of the Board of Directors in March 2023. Mr. Saunders initially served as CEO from 2010 until 2013, when the company was acquired by Bausch Health Companies Inc. (then known as Valeant Pharmaceuticals, Inc.).
Mr. Saunders previously co-founded and served as Chairman of the Board of Vesper Healthcare Acquisitions Corp. Prior to that, he was Chairman, President and CEO of Allergan plc. until the company’s $63 billion acquisition by AbbVie Inc in 2020. Before that, he was President and CEO and a director of Forest Laboratories Inc., until that company’s $25 billion merger with Actavis plc. in 2014, when he was named CEO of the combined business. He then successfully led Actavis’ $66 billion acquisition of Allergan.

Read more about this event: https://news.miami.edu/stories/2024/0...